Christian Jobin
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (10)
The intestinal microbiota has been shown to influence host-derived microRNAs (miRNAs), small regulatory RNAs involved in host-pathogen interactions. However, the specific role of individual bacterial species in modulating host extracellular vesicles (EV)-derived miRNA profiles remains unclear. We compared stool miRNA profiles from three groups: (i) Germ-free (GF) mice, (ii) mice colonized with a consortium of 13 bacteria (C13), and (iii) mice colonized with C13 and Campylobacter jejuni 81–176 (C13 + C. jejuni ). miRNA profiling revealed unique differential expression of 8 miRNAs in C13 vs GF, 38 in C13 + C. jejuni vs C13, and 159 in C13 + C. jejuni vs GF ( P adj < 0.05), indicating a substantial shift in host miRNA landscape following C. jejuni exposure. Notably, C13 + C. jejuni mice showed increased expression of miRNAs predicted to target bacterial virulence genes, suggesting a potential host response mechanism aimed at regulating microbial activity. Integration with spatial transcriptomics of the mouse colon revealed that specific EV-derived miRNAs, including mmu-miR-155-5p, mmu-miR-122-5p, mmu-miR-21a-5p, mmu-let-7i-5p, and mmu-miR-142a-3p target epithelial genes involved in immune regulation, inflammation, and barrier function. C. jejuni exposure selectively enriched these host miRNAs, suggesting a mechanism by which EVs modulate epithelial transcriptional responses and potentially influence microbial gene expression. In conclusion, C. jejuni infection modified host EV-derived miRNA expression profile that may have a potential to bind to the bacterial gene targets. IMPORTANCE Host-derived microRNAs (miRNAs) are known to regulate bacterial gene expression and maintain gut homeostasis. However, how these miRNAs survive harsh gut conditions to remain functional is not fully understood. This study tested whether extracellular vesicles (EV) carry microRNAs in the gut and whether infection with the enteric pathogen Campylobacter jejuni alters the microRNA profile packaged in these vesicles. We utilized fecal samples from mice, either maintained germ-free (absence of microbiota) or, C13 (defined 13 bacterial consortium), and C13 + C. jejuni to analyze the EV-derived miRNA pattern across the groups. Our results revealed distinct sets of miRNAs in each group and suggested possible interactions between these miRNAs and gene transcripts from both the host and bacteria. These findings provide new insights into how C. jejuni infection may change communication between the host and its microbiome, potentially affecting gut health and disease.
Year:
2026
C. difficile induces the activation of myeloid cells and IL17-producing lymphoid subsets. Multiparameter flow cytometry analysis of colonic lamina propria innate (myeloid and ILCs) and adaptive immune cell populations of LPL isolated from colons collected at 2 weeks p.i. from GF Apc Min/+ mice gavaged with the 3728T isolates with ( n = 5) or without ( n = 6) C. difficile strain CIm_3728T. Results from two independent experiments. A, Opt-SNE projection of myeloid and ILC populations. B, Dot plots of myeloid cell type abundance as a percentage of the CD45 population. C, Representative gating of DCs, PMN, and IL17 expression by ILC3 cells. D, Opt-SNE projection of adaptive populations (B and T lymphocytes). E, Dot plots of changes in abundance of lymphoid populations with C. difficile . F, Representative gating of lymphoid subsets. Opt-SNE projections are used for visualization purposes only. Statistical analyses in B and E represent Mann–Whitney t tests based on the gating in C and F , respectively. DC, dendritic cells; EILP, early innate lymphoid progenitors; ILC, innate lymphoid cells; IMC, innate myeloid cells; LPL, lamina propria leukocytes; MAC, macrophages; MO, monocytic cells; NK, natural killer; PMN, polymorphonuclear cells; Treg, regulatory T cells.
Year:
2025
C. difficile strains isolated from human colon cancer mucosa drive colonic tumor formation in GF Apc Min/+ mice. A and B, Variation in colonic tumorigenic potential in GF Apc Min/+ mice at 12 to 14 weeks post-inoculation (p.i.) by individual BF-positive tumor (BF + T; A ) or BF-negative tumor (BF − T; B ) colorectal cancer mucosal samples from six patients. n = 6–8 mice per group, from two independent experiments. C, 16S rRNA amplicon sequencing relative abundances of the top 20 species in the six patient tumor slurry inocula and 12 to 14 weeks p.i. stools from mice gavaged with the tumor slurries. D, A consortium of 30 bacterial isolates derived from GF mice gavaged with the 3728T slurry recapitulated colonic tumorigenesis of the original 3728T slurry. n = 5–11 mice per group. E and F, Colonic tumor counts ( E ) and representative methylene blue staining ( F ) of colonic tumors (arrows) at 12 weeks p.i. in a vancomycin/gentamicin model (see Methods) of chronic colonization with nontoxigenic (TcdA − TcdB − ) or toxigenic (TcdA + TcdB + ) C. difficile strains. n = 5–18 mice per group, from two independent experiments. G and H, Colonic tumor counts ( G ) and representative methylene blue staining ( H ) of colonic tumors (arrows) from GF Apc Min/+ mice gavaged with the 3728T isolates with or without the CIm_3728T or CIm_3752T C. difficile strains. n = 6–8 mice per group. I, Colonic tumors induced in GF Apc Min/+ mice gavaged with either the 3979T slurry or the 3979T slurry with C. difficile strain CIm_3728T at 10 weeks p.i. The cross represents a mouse death. n = 7–8 mice per group. Statistical significance was calculated via Kruskal–Wallis followed by Mann–Whitney tests. Mann–Whitney P values are shown. ns, not significant.
Year:
2025
C. difficile –associated tumorigenesis is toxin B (TcdB)–dependent. A, GF Apc Min/+ mice were gavaged with WT or isogenic tcdA − , tcdB − , or tcdA − tcdB − TargeTron mutant strains of M7404, an epidemic strain of ribotype 027, either simultaneously with the 3728T isolates or 1 week later. Tumor counts at 8 weeks p.i. were analyzed. Crosses represent mouse deaths. n = 2–7 mice per group, from two independent experiments. B, Summary graph showing colonic tumor induction of all TcdB − versus TcdB + M7404 strains in combination with the 3728T isolates in GF Apc Min/+ mice. C and D, C. difficile stool CFUs and Vero toxin titers. Mann–Whitney P value is shown. E–M, Experimental design for 2-week experiments with M7404 strains: mice were gavaged with the 3728T isolates − Cd 1 week prior to C. difficile gavage with either the tcdB − ( n = 6 mice) or WT M7404 strain ( n = 8 mice). F and G, C. difficile stool CFUs and toxin titers. H, Representative crypts with BF invasion, stained in red for EUB338 and yellow for Cd198. I, C. difficile tissue invasion. J, Representative H&E images and quantitation of histopathologic changes at 2 weeks p.i. K, Representative images of β-catenin, Ki-67, and PCNA immunofluorescent staining of distal colonic epithelium in M7404 TcdB − (top)– versus M7404 WT (bottom)–inoculated mice. Arrow denotes a dysplastic focus in the M7404 WT–inoculated mouse. L, Quantitation and representative images of crypt depth in the distal colon. M, Host gene expression in colon. Dashed line represents 3728T isolates − Cd-negative control. Statistics shown are Mann–Whitney t tests. ns, not significant.
Year:
2025
C. difficile and the 3728T slurry induce rapid tumorigenesis in GF Apc Min/+ mice despite representing only a fraction of the luminal and mucosal microbiota. A and B, Twenty-five GF Apc Min/+ mice were gavaged with the 3728T slurry; five mice were sacrificed per time point. A, Colonic microadenoma and adenoma counts. B, Hematoxylin and eosin (H&E) staining of a representative microadenoma is shown from a mouse at 2 weeks p.i. (top), whereas a large adenoma coated by a dense BF is shown from a mouse at 4 weeks p.i. (bottom). Confocal imaging of Carnoy's-fixed mouse distal colons stained with the EUB338 universal probe (magenta), Cd198 C. difficile probe (yellow), or DAPI counterstain (blue). White arrows highlight individual C. difficile rods. C and D , Microadenomas ( C ) and FISH staining ( D ) of 2 weeks p.i. distal colons from GF Apc Min/+ mice gavaged with the 3728T isolates ± C. difficile CIm_3728T. Crosses represent mouse deaths. n = 6 mice per group, from two independent experiments. FISH images represent three separate mice per inoculum. White arrowheads denote areas with occasional mucus-invasive BFs directly interacting with epithelium in mice gavaged with the 3728T isolates without C. difficile (3728T isos – Cd). White arrows (bottom) represent areas with crypt-invasive BFs in the mice gavaged with the 3728T isolates + C. difficile . Statistical significance in A and C was calculated via Kruskal–Wallis followed by Mann–Whitney tests. Mann–Whitney P values are shown. E, Relative abundance (RA) of C. difficile derived from 16S rRNA amplicon sequencing of the original human slurry (3728T) or mouse stool obtained at sacrifice of mice in the time course experiment following gavage with the 3728T slurry. dpi, days post-inoculation. F, FISH of the original patient tumor 3728T. CRC, colorectal cancer. G–M, scRNA-seq and gene set enrichment analysis of 3728T slurry ( n = 3)– versus 3979T slurry ( n = 3)–gavaged GF Apc Min/+ mice at 2 weeks p.i. Heat maps depict genes enriched in canonical Wnt ( G ) or ROS ( H ) signaling pathways, with Wilcoxon rank-sum test P values above each gene. I, Inflammatory signaling pathways enriched in specific cell types from 3728T slurry– versus 3979T slurry–gavaged mice at 2 weeks p.i. KEGG, Kyoto Encyclopedia of Genes and Genomes. J, Inhibition and activation of the most significant upstream regulators in either progenitor or differentiated colonocytes. Expression log ratio is an effect size statistic. K and L, Network analysis of transcription factors from IPA upstream regulators enriched in the progenitor cell gene list revealed activation of Wnt/Myc signaling and proliferation, respectively. Lines connect transcription factors with shared target genes in the gene list. Darker lines indicate a greater number of shared target genes. M, Similar network analysis for differentiated colonocytes showed activation of the innate immune response.
Year:
2025
The intestinal microbiota influences host susceptibility to Campylobacter jejuni ( C. jejuni ) infection. However, the interaction between specific intestinal bacteria and the C. jejuni- mediated host response is unclear. We established a defined consortium of bacteria to delineate C. jejuni -induced host responses. Three groups of germ-free (GF) Il10 -/- mice were used in this study: 1) mice colonized with a defined consortium of 13 bacterial isolates (C13) representing the four most prominent phyla in the mouse gut. 2) C13 plus C. jejuni 81-176 and 3) GF alone. The C13 + C. jejuni group induced significant intestinal inflammation and inflammatory mRNA gene expression compared to mice colonized with C13. 16S rRNA gene sequencing revealed an increased relative abundance of Escherichia and Paraclostridium in C13 + C. jejuni . Fluorescence in situ hybridization (FISH) and RNAscope integrated with spatial transcriptomics provided a high-resolution map of infection-induced gene expression, revealing localized immune responses and epithelial remodeling in defined colonic regions. Region-specific analysis further demonstrated that tissue-associated C. jejuni differentially modulates host gene expression compared to tissue-associated Enterobacteriaceae . Collectively, these findings demonstrate the potential of defined microbial consortia and spatially resolved transcriptomics to dissect the complex interplay between host, microbiota, and pathogens during enteric infection.
Year:
2025
Background Inflammatory bowel diseases (IBDs) are characterised by dysbiosis and a leaky gut. The NADPH oxidase dual oxidase 2 (DUOX2) is upregulated in patients with IBD, yet its role in driving the disease remains unclear. Objective We interrogated the functional consequences of epithelial DUOX2 activity for the host and microbiome. Design DUOX2 function was studied in mice with epithelial-specific DUOX2 overactivation (vTLR4), inactivation (vTLR4 DUOXA IEC-KO) and wild-type controls. We assessed the effect of dysbiosis on DUOX2 signalling and intestinal permeability (FITC-dextran, serum zonulin, bacterial translocation) with germ-free (GF) mice engrafted with IBD or healthy microbiota. RNA sequencing of colonic mucosa and microbiota and faecal metabolomics were used to characterise the host–microbe interface. Mechanistic studies were conducted in mouse colonoids, IBD biopsies and patient serum samples. Results DUOX2 activity increased permeability and bacterial translocation and induced subclinical inflammation in vTLR4 mice. GF vTLR4 mice had increased DUOX2 activity and permeability but no subclinical inflammation. In patients with IBD, DUOX2 expression was positively associated with plasma zonulin levels and negatively associated with ZO-1 expression. Engraftment of GF mice with IBD stool increased DUOX2 activity and triggered low-grade inflammation and permeability defects in mice. DUOX2 activity functionally altered the microbiome, reduced butyrate metabolism and promoted proinflammatory and pro-oncogenic bacterial metabolites. Butyrate and histone deacetylase (HDAC) inhibitors blocked DUOX2 activation and reversed its effects. Conclusions Elevated DUOX2 signalling contributes to epithelial barrier dysfunction, microbiome alterations and subclinical inflammation. Butyrate and HDAC inhibitors reversed these effects, indicating that DUOX2 may be a therapeutic target in IBD.
Year:
2025
To identify causal links between gut microbes and tumorigenesis, we colonized groups of germ-free colon tumor-susceptible mice ( Apc Min/+ ; Il10 −/− ) with 15 cultured human fecal microbiotas from healthy individuals, as well as patients with inflammatory bowel disease and colorectal cancer. The number of colonic tumors in Apc Min/+ ; Il10 −/− mice varied by donor microbiota but not by the health status of the donor. In vitro screens of host cell proliferation, genotoxicity, and inflammation in bacteria-mammalian cell cocultures revealed that genotoxicity best predicted tumorigenic microbes in vivo with genotoxic microbes present in all tested individuals. The genotoxic subset of strains from each donor induced more tumors than the complete community – even when the complete community was not tumorigenic. Combining genotoxic microbes from multiple sources increased tumor number and decreased the time to tumor onset. Together these results suggest that most individuals harbor genotoxic bacterial strains and the balance of genotoxic to protective strains determines the timing and severity of tumorigenesis in vivo.
Year:
2025
Colibactin is a genotoxic secondary metabolite produced by certain Enterobacteriaceae strains that populate the intestine and produces a specific mutational signature in human colonocytes. However, the host pathways involved in colibactin response remain unclear. To address this gap, we performed genome-wide CRISPR/Cas9 knockout screens and RNA sequencing utilizing live pks + bacteria and a synthetic colibactin analog. We identified 20 enriched genes with a MAGeCK score of >2.0 in both screens, including proteasomal subunits (e.g., PSMG4 and PSMD4 ), RNA processing factors (e.g., SF1 and PRPF8 ), and RNA polymerase III (e.g., CRCP ), and validated the role of PSMD4 in colibactin sensitization. PSMD4 knockout in HEK293T and HT-29 cells promoted cell viability and ameliorated G2-M cell cycle arrest but did not affect the amount of phosphorylated H2AX foci after exposure to synthetic colibactin 742. Consistent with these observations, PSMD4 −/− cells had a significantly higher colony formation rate and bigger colony size than control cells after 742 exposure. These findings suggest that PSMD4 regulates cell cycle arrest following colibactin-induced DNA damage and that cells with PSMD4 deficiency may continue to replicate despite DNA damage, potentially increasing the risk of malignant transformation. IMPORTANCE Colibactin has been implicated as a causative agent of colorectal cancer. However, colibactin-producing bacteria are also present in many healthy individuals, leading to the hypothesis that some aspects of colibactin regulation or host response dictate the molecule’s carcinogenic potential. Elucidating the host-response pathways involved in dictating cell fate after colibactin intoxication has been difficult, partially due to an inability to isolate the molecule. This study provides the first high-throughput CRISPR/Cas9 screening to identify genes conferring colibactin sensitivity. Here, we utilize both bacterial infection and a synthetic colibactin analog to identify genes directly involved in colibactin response. These findings provide insight into how differences in gene expression may render certain individuals more vulnerable to colibactin-initiated tumor formation after DNA damage.
Year:
2025
Hematopoiesis governs the generation of immune cells through the differentiation of hematopoietic stem cells (HSC) into various progenitor cells, a process controlled by intrinsic and extrinsic factors. Among extrinsic factors influencing hematopoiesis is the microbiota, or the collection of microorganisms present in various body sites. The microbiota has a profound impact on host homeostasis by virtue of its ability to release various molecules and structural components, which promote normal organ function. In this review, we will discuss the role of microbiota in influencing hematopoiesis and how disrupting the microbiota/host network could lead to hematologic malignancies, as well as highlight important knowledge gaps to move this field of research forward. Significance: Microbiota dysfunction is associated with many pathologic conditions, including hematologic malignancies. In this review, we discuss the role of microbiota in influencing hematopoiesis and how disrupting the microbiota/host network could lead to hematologic malignancies. Understanding how the microbiota influences hematologic malignancies could have an important therapeutic impact for patients.
Year:
2023
Collaborators (14)
Raad Z Gharaibeh
Associate Professor, Director, UF Health Cancer Center Microbiome Genomics
University of Florida
Jinmai Jiang
Research Assistant Professor
University of Florida
Jeremiah Faith
Icahn School of Medicine at Mount Sinai
franck housseau
Associate Professor
Johns Hopkins University School of Medicine
Martha Shrubsole
Research Professor
Vanderbilt University
Ken Lau
Associate Professor
Vanderbilt University School of Medicine
Cynthia L. Sears
Johns Hopkins University School of Medicine
Nicholas Markham
Assistant Professor
Vanderbilt University Medical Center
Graham Britton
Icahn School of Medicine at Mount Sinai
Fengyi Wan
Professor
Johns Hopkins University
Patricia J. Simner
Johns Hopkins University School of Medicine
Karen C. Carroll
Johns Hopkins University School of Medicine
Robert Coffey
Professor
Vanderbilt University Medical Center
Maria T. Abreu
Executive Director
University of Miami Hospital
Make your next move.
Prepare your application
Review drafts before you send them.